Subheading 3006.93 · Section VI
Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses
exported in , down 10.6% on , to 44 countries.
Five-year trend
Top 5 markets in 2025
Every market for this product, with its growth, share, ECGC rating and any trade agreement with India. Use it to spot markets that are growing, sizeable and low-risk.
| Market | Value 2025 | Change | ECGC rating |
|---|
ECGC ratings are ECGC's short-term country classification (see the ratings page); putting them beside trade figures is Exportsmitra's own analysis, not ECGC's. Yearly growth is the average over the years shown.
India's share of each market's imports of 3006, and who else sells there.
| Market | Its imports | India's share |
|---|---|---|
United States 2025
| 5.23 bn | 2.6%11th |
Malaysia 2025
| 820 mn | 12%1st |
Canada 2025
| 492 mn | 1.6%16th |
United Kingdom 2025
| 868 mn | 0.8%21st |
Turkey 2025
| 144 mn | 4.6%6th |
Tanzania 2025
| 13.4 mn | 45%1st |
Ghana 2025
| 13.0 mn | 39%1st |
Nigeria 2025
| 35.8 mn | 14%3rd |
France 2025
| 603 mn | 0.6%27th |
Kenya 2025
| 28.8 mn | 12%4th |
The markets that buy the most 3006 where India has under 5%: openings, or where others are stronger.
| Market | Its imports | India's share |
|---|---|---|
United States 2025
| 5.23 bn | 2.6%11th |
Netherlands 2025
| 3.17 bn | <0.1%26th |
Germany 2025
| 1.84 bn | 0.1%32nd |
China 2025
| 1.30 bn | <0.1%37th |
Belgium 2025
| 1.24 bn | <0.1%22nd |
United Kingdom 2025
| 868 mn | 0.8%21st |
Japan 2025
| 689 mn | <0.1%30th |
France 2025
| 603 mn | 0.6%27th |
Italy 2025
| 589 mn | 0.3%21st |
Canada 2025
| 492 mn | 1.6%16th |
US$ million. Each market's own import figures as reported to UN Comtrade (the year shown; some countries report late), so they differ from India's export figures above. Open a market for its six biggest suppliers. Exportsmitra's figures, not ECGC's.
Source: Harmonized System 2022 edition (World Customs Organization), from the UN Comtrade classification list.